So far, more than 100 different cannabinoids have been identified, and there is a growing body of evidence supporting the clinical benefits of this class of compounds in treating the symptoms of a wide variety of chronic health conditions
Roots Analysis is pleased to announce the publication of its recent study, titled, “Endocannabinoid System Targeted Therapeutics Market, 2020-2030.“
The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of endocannabinoid system targeting drugs, over the next decade. The report features an in-depth analysis, highlighting the diverse capabilities of stakeholders engaged in this domain. In addition to other elements, the study includes:
Key companies covered in the report
For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/endocannabinoid-therapeutics/316.html
Other Recent Offerings
Contact:
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
[email protected]
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
- Everyone wants to pass the exam in first try. Visit CertsAdvice website for an easy preparation of your exam
- One weekend after demonstrators staged rallies in more than 80 cities to show support for the legisl
- The whole point of certification is that it independently and impartially verifies that you are complying to a standard. Irrespective of regardless
- After the discovery of the unexploded bomb near King George V Dock on Sunday, the airport canceled a